KAZUHIRO OKA to Humans
This is a "connection" page, showing publications KAZUHIRO OKA has written about Humans.
Connection Strength
0.170
-
Adeno-Associated Virus as Gene Delivery Vehicle into the Retina. Methods Mol Biol. 2020; 2092:77-90.
Score: 0.017
-
A neuronal VLDLR variant lacking the third complement-type repeat exhibits high capacity binding of apoE containing lipoproteins. Brain Res. 2009 Jun 18; 1276:11-21.
Score: 0.008
-
Sustained phenotypic correction in a mouse model of hypoalphalipoproteinemia with a helper-dependent adenovirus vector. Gene Ther. 2007 Feb; 14(3):191-202.
Score: 0.007
-
Helper-dependent adenoviral vectors. Curr Protoc Hum Genet. 2005 Nov; Chapter 12:Unit 12.13.
Score: 0.006
-
Clinical and Prognostic Utility of the Essential Frailty Toolset in Older Patients With Heart Failure. J Am Geriatr Soc. 2025 Nov; 73(11):3455-3463.
Score: 0.006
-
Targeting site-specific chromosome integration. Acta Biochim Pol. 2005; 52(2):285-91.
Score: 0.006
-
Inhibition and regression of atherosclerotic lesions. Acta Biochim Pol. 2005; 52(2):311-9.
Score: 0.006
-
Construction and characterization of helper-dependent adenoviral vectors for sustained in vivo gene therapy. Methods Mol Med. 2005; 108:329-50.
Score: 0.006
-
Prevalence and Prognostic Value of Cachexia Diagnosed by New Definition for Asian People in Older Patients With Heart Failure. J Cachexia Sarcopenia Muscle. 2024 Dec; 15(6):2660-2668.
Score: 0.006
-
Lymphocyte-to-C-reactive protein ratio and score in patients with heart failure: Nutritional status, physical function, and prognosis. ESC Heart Fail. 2024 Dec; 11(6):3723-3731.
Score: 0.006
-
Liver-directed gene therapy for dyslipidemia and diabetes. Curr Atheroscler Rep. 2004 May; 6(3):203-9.
Score: 0.006
-
Impact of Multidomain Frailty on the Mode of Death in Older Patients With Heart Failure: A Cohort Study. Circ Cardiovasc Qual Outcomes. 2024 May; 17(5):e010416.
Score: 0.006
-
Association and Prognostic Value of Multidomain Frailty Defined by Cumulative Deficit and Phenotype Models in Patients With Heart Failure. Can J Cardiol. 2024 04; 40(4):677-684.
Score: 0.006
-
Predictive value of the Ishii score for sarcopenia and the prognosis of older patients hospitalized with heart failure. Geriatr Gerontol Int. 2024 Jan; 24(1):147-153.
Score: 0.006
-
Prevalence and prognostic impact of the coexistence of cachexia and sarcopenia in older patients with heart failure. Int J Cardiol. 2023 06 15; 381:45-51.
Score: 0.005
-
Prognostic implications of six-minute walking distance in patients with heart failure with preserved ejection fraction. Int J Cardiol. 2023 05 15; 379:76-81.
Score: 0.005
-
Recent advances in liver-directed gene therapy for dyslipidemia. Curr Atheroscler Rep. 2002 May; 4(3):199-207.
Score: 0.005
-
Sex differences in the prevalence and prognostic impact of physical frailty and sarcopenia among older patients with heart failure. Nutr Metab Cardiovasc Dis. 2022 Feb; 32(2):365-372.
Score: 0.005
-
Recent advances in liver-directed gene therapy: implications for the treatment of dyslipidemia. Curr Opin Lipidol. 2000 Apr; 11(2):179-86.
Score: 0.004
-
Tissue-specific inhibition of apolipoprotein B mRNA editing in the liver by adenovirus-mediated transfer of a dominant negative mutant APOBEC-1 leads to increased low density lipoprotein in mice. J Biol Chem. 1997 Jan 17; 272(3):1456-60.
Score: 0.004
-
Transcription of the human hepatic lipase gene is modulated by multiple negative elements in HepG2 cells. Gene. 1996 Nov 21; 180(1-2):69-80.
Score: 0.003
-
Functional Differences of Very-Low-Density Lipoprotein Receptor Splice Variants in Regulating Wnt Signaling. Mol Cell Biol. 2016 10 15; 36(20):2645-54.
Score: 0.003
-
Partial structure of the mouse glucokinase gene. Genomics. 1995 Oct 10; 29(3):751-4.
Score: 0.003
-
Mouse very-low-density-lipoprotein receptor (VLDLR) cDNA cloning, tissue-specific expression and evolutionary relationship with the low-density-lipoprotein receptor. Eur J Biochem. 1994 Sep 15; 224(3):975-82.
Score: 0.003
-
Human very-low-density lipoprotein receptor complementary DNA and deduced amino acid sequence and localization of its gene (VLDLR) to chromosome band 9p24 by fluorescence in situ hybridization. Genomics. 1994 Mar 15; 20(2):298-300.
Score: 0.003
-
Mutant cohesin in premature ovarian failure. N Engl J Med. 2014 Mar 06; 370(10):943-949.
Score: 0.003
-
[Structure and regulation of hepatic lipase]. Seikagaku. 1993 Dec; 65(12):1516-21.
Score: 0.003
-
A missense (Asp250----Asn) mutation in the lipoprotein lipase gene in two unrelated families with familial lipoprotein lipase deficiency. J Lipid Res. 1992 May; 33(5):745-54.
Score: 0.003
-
Carbohydrate response element-binding protein (ChREBP) plays a pivotal role in beta cell glucotoxicity. Diabetologia. 2012 Jun; 55(6):1783-96.
Score: 0.002
-
CREB-activity and nmnat2 transcription are down-regulated prior to neurodegeneration, while NMNAT2 over-expression is neuroprotective, in a mouse model of human tauopathy. Hum Mol Genet. 2012 Jan 15; 21(2):251-67.
Score: 0.002
-
Liver-specific expression of an exogenous gene controlled by human apolipoprotein A-I promoter. Int J Pharm. 2010 Oct 15; 398(1-2):161-4.
Score: 0.002
-
ANKRD1, the gene encoding cardiac ankyrin repeat protein, is a novel dilated cardiomyopathy gene. J Am Coll Cardiol. 2009 Jul 21; 54(4):325-33.
Score: 0.002
-
Essential role of Smad3 in angiotensin II-induced vascular fibrosis. Circ Res. 2006 Apr 28; 98(8):1032-9.
Score: 0.002
-
Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice. Gene. 2004 Mar 03; 327(2):153-60.
Score: 0.001
-
Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia. Circulation. 2003 Jun 03; 107(21):2726-32.
Score: 0.001
-
Apolipoprotein B: from editosome to proteasome. Recent Prog Horm Res. 2000; 55:93-125; discussion 126.
Score: 0.001
-
Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1. J Biol Chem. 1996 Oct 18; 271(42):25981-8.
Score: 0.001
-
Tissue-specific expression and cholesterol regulation of acylcoenzyme A:cholesterol acyltransferase (ACAT) in mice. Molecular cloning of mouse ACAT cDNA, chromosomal localization, and regulation of ACAT in vivo and in vitro. J Biol Chem. 1995 Nov 03; 270(44):26192-201.
Score: 0.001
-
Alternative mRNA splicing and differential promoter utilization determine tissue-specific expression of the apolipoprotein B mRNA-editing protein (Apobec1) gene in mice. Structure and evolution of Apobec1 and related nucleoside/nucleotide deaminases. J Biol Chem. 1995 Jun 02; 270(22):13042-56.
Score: 0.001
-
Structure of the mouse cholesterol 7 alpha-hydroxylase gene. Genomics. 1994 May 01; 21(1):244-7.
Score: 0.001
-
Regulation of hepatic triglyceride lipase by thyroid hormone in HepG2 cells. J Lipid Res. 1993 Jun; 34(6):961-70.
Score: 0.001
-
A missense mutation (Trp86----Arg) in exon 3 of the lipoprotein lipase gene: a cause of familial chylomicronemia. Am J Hum Genet. 1992 Jun; 50(6):1275-80.
Score: 0.001